Other Angus Journal
event sites …
  1. Beef Improvement Federation
  2. Applied Reproductive Strategies in Beef Cattle
  3. National Angus Conference
  4. Range Beef Cow Symposium

Visit the Angus Journal
topic library …

The topic sites in our library offer gateways to information on body condition scoring, beef cow efficiency, country-of-origin labeling, targeting the Certified Angus Beef® brand and more.

Sign up for ...
  1. Angus Journal
  2. Angus Beef Bulletin
  3. Angus Journal Daily
  4. Angus Beef Bulletin EXTRA



Angus Journal

Copyright © 2014
Angus Journal


Bayer’s Annihilator™ Polyzone®
Makes Insect Control Easy All Season Long

Broad-spectrum premise spray offers residual effectiveness of up to 90 days in a single treatment.

SHAWNEE, Kan. (Jan. 28, 2014) — Bayer HealthCare LLC Animal Health Division has announced the introduction of a broad-spectrum premise spray called Annihilator™ Polyzone®. The product provides livestock producers with long-term control of crawling, flying and wood-infesting pests. Bayer’s proprietary technology allows the product to withstand aggressive surfaces, weather and wash-off conditions for up to 90 days. This residual enables users to maintain control with fewer applications, which can result in reduced labor.

“Calf facilities in the summer are one of the worst places you could be for flies,” said Dairy Manager Benny Rector from Hilmar, Calif. “We sprayed calf pens before we put calves in them, and we sprayed the surrounding area. The residual effects lead to less labor for me to put it on, and it’s a constant — maintained control over those 8-12 weeks. That’s the big thing — it’s a constant kill.”

The proprietary technology within Annihilator Polyzone forms a protective layer between the active ingredient particles and the applied area adhering them to the surface. As the Polyzone crystals erode over time, the active ingredient, deltamethrin, is slowly released, leading to effective control for up to 90 days. This residual gives users the ability to apply the product in many areas, as well as hard-to-spray areas.

“With Annihilator Polyzone, we are providing livestock producers an effective long-term premise spray,” says Cary Christensen, veterinarian and director of Bayer's Food Animal Business Unit. “This is part of the Bayer Defense Point System, an integrated pest control management system designed to help protect animal operations from pests. Because of the significant economic impact — and health and wellness affect — flies have on livestock operations, producers need additional tools to help manage flies.”

Annihilator Polyzone is one of the latest innovations in a portfolio of brands that help make Bayer a leading provider of pest management solutions.

About Annihilator Polyzone:
Annihilator Polyzone is sold by the pint, distributed by Bayer HealthCare and available through Bayer-approved distributors. For more information about Annihilator Polyzone, or to obtain a product label, call Bayer Veterinary Services at +1-800-422-9874 or visit www.bayerlivestock.com.

About Bayer HealthCare:
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 18.6 billion (2012), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 54,900 employees (Dec. 31, 2012) and is represented in more than 100 countries. More information at www.healthcare.bayer.com.

Find more information at www.animalhealth.bayerhealthcare.com. Follow us on Facebook: www.facebook.com/healthcare.bayer. Follow us on Twitter: https://twitter.com/Bayer4AnimalsUS.

Forward-Looking Statements: This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Editor’s Note: This article was provided as a news release by Bayer Health Care LLC and as such may be redistributed. For additional information contact Staci Gouveia at 913-268-2577 or Lauren Dorsch at 913-268-2747.